These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 6944971

  • 1. [Clinical significance of HDL-cholesterol].
    Reuter W, Herrmann W.
    Z Gesamte Inn Med; 1981 Jul 15; 36(14):473-9. PubMed ID: 6944971
    [Abstract] [Full Text] [Related]

  • 2. [High-density lipoproteins in children with coronary diseases].
    Oberhänsli I, Pometta D, Micheli H, Raymond L.
    Helv Paediatr Acta; 1981 Jul 15; 36(2):135-47. PubMed ID: 7251385
    [Abstract] [Full Text] [Related]

  • 3. [Hyperlipoproteinemia, HDL-cholesterol and arteriosclerosis indices].
    Herrmann W, Reuter W.
    Z Gesamte Inn Med; 1982 Dec 15; 37(24):830-3. PubMed ID: 6963524
    [No Abstract] [Full Text] [Related]

  • 4. [HDL-cholesterol and family incidence of coronary disease in the Genevan population].
    Suenram A, Pometta D, von der Weid N.
    Schweiz Med Wochenschr; 1983 Dec 17; 113(50):1926-8. PubMed ID: 6665538
    [Abstract] [Full Text] [Related]

  • 5. [HDL-cholesterol and cardiovascular diseases--gerontological aspects].
    Reuter W, Herrmann W.
    Z Alternsforsch; 1982 Dec 17; 37(5):315-28. PubMed ID: 7157847
    [Abstract] [Full Text] [Related]

  • 6. The effect on HDL cholesterol of oxprenolol and atenolol.
    Kjeldsen SE, Eide I, Leren P, Foss OP, Holme I, Eriksen IL.
    Scand J Clin Lab Invest; 1982 Sep 17; 42(5):449-53. PubMed ID: 6130595
    [Abstract] [Full Text] [Related]

  • 7. [Vitamin E megadoses and their effect on HDL cholesterol levels in patients with atherosclerotic complications (author's transl)].
    Turay J, Beseda I, Michalcová A.
    Cas Lek Cesk; 1981 Dec 03; 120(48):1432-4. PubMed ID: 6947861
    [No Abstract] [Full Text] [Related]

  • 8. Effects of posture on serum cholesterol fractions, cholesterol ratio and triglycerides.
    Kjeldsen SE, Eide I, Leren P, Foss OP.
    Scand J Clin Lab Invest; 1983 Apr 03; 43(2):119-21. PubMed ID: 6577578
    [Abstract] [Full Text] [Related]

  • 9. [Clinical aspects of the problem of hyperlipoproteinemia and age].
    Reuter W.
    Z Gesamte Inn Med; 1981 Mar 03; 36(5):141-5. PubMed ID: 7018098
    [Abstract] [Full Text] [Related]

  • 10. [Serum high density lipoprotein cholesterol in a population of asymptomatic men in Santiago, Chile].
    Arteaga A, Maiz A, Donoso V, Aravena M, Acosta AM.
    Rev Med Chil; 1983 Feb 03; 111(2):115-23. PubMed ID: 6580687
    [No Abstract] [Full Text] [Related]

  • 11. Terbutaline raises high-density-lipoprotein-cholesterol levels.
    Hooper PL, Woo W, Visconti L, Pathak DR.
    N Engl J Med; 1981 Dec 10; 305(24):1455-7. PubMed ID: 6946283
    [No Abstract] [Full Text] [Related]

  • 12. Lipid measurements for coronary risk assessment: a review.
    Berg LH.
    Am J Med Technol; 1981 Jul 10; 47(7):539-43. PubMed ID: 7025628
    [Abstract] [Full Text] [Related]

  • 13. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K, Nakai T, Tamai T, Kutsumi Y, Kobayashi T, Hayashi T, Yamada S, Takeda R.
    Artery; 1982 Jul 10; 10(4):266-85. PubMed ID: 7181672
    [Abstract] [Full Text] [Related]

  • 14. HDL-cholesterol (HDL-C) changes during and after intensive long-lasting exercise.
    Berg A, Johns J, Baumstark M, Keul J.
    Int J Sports Med; 1981 May 10; 2(2):121-3. PubMed ID: 6949879
    [No Abstract] [Full Text] [Related]

  • 15. [Rapid effect of glucuronyl glucosamine glycan sulfate on the blood levels of HDL-cholesterol in vascular diseases].
    Ferlito S, La Spina E, Cultrera E, Puleo F, Carrà G.
    Arch Sci Med (Torino); 1982 May 10; 139(2):175-81. PubMed ID: 7138283
    [Abstract] [Full Text] [Related]

  • 16. [The lipoproteic state in patients with coronary heart disease (author's transl)].
    Catalano M, Carzaniga G, Garimoldi M, Sala R, Castelfranco M, Libretti A.
    G Ital Cardiol; 1981 May 10; 11(12):1944-7. PubMed ID: 7346295
    [Abstract] [Full Text] [Related]

  • 17. [Changes in serum lipoproteins in cerebrovascular disease (author's transl)].
    Bruck J, Fischer M, Tschabitscher H.
    Wien Klin Wochenschr; 1981 Oct 16; 93(19):604-9. PubMed ID: 7324470
    [Abstract] [Full Text] [Related]

  • 18. The biochemical effects of antihypertensive agents and the impact on atherosclerosis.
    Lowenstein J, Neusy AJ.
    J Cardiovasc Pharmacol; 1982 Oct 16; 4 Suppl 2():S262-4. PubMed ID: 6177970
    [No Abstract] [Full Text] [Related]

  • 19. [Plasma glycosaminoglycans in patients with coronary disease and hyperlipidemia].
    Giannini SD, Strunz CM, Forti N, Credidio Rde A, Diament J, Dereviacki BE, de Góis JM, de Serro-Azul LG.
    Arq Bras Cardiol; 1986 May 16; 46(5):307-10. PubMed ID: 3471185
    [No Abstract] [Full Text] [Related]

  • 20. High-density lipoproteins: epidemiologic profile and risks of coronary artery disease.
    Kannel WB.
    Am J Cardiol; 1983 Aug 22; 52(4):9B-12B. PubMed ID: 6577783
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.